Department of Microbiology, AIIMS, New Delhi, India.
Epidemiol Infect. 2012 Nov;140(11):2110-6. doi: 10.1017/S0950268811002883. Epub 2012 Jan 16.
Due to the poor positive predictive value of nucleic acid amplification tests (NAATs) for gonorrhoea when applied to a low-prevalence setting, current guidelines recommend the use of supplementary polymerase chain reaction (PCR) targeting a different gene for confirmation of true positives in urogenital specimens. This study sought to standardize and evaluate performance of an in-house opa gene-based PCR assay for gonorrhoea compared to assays targeting the porA pseudogene and 16S rRNA gene. Four hundred samples (300 endocervical, 100 urethral swabs) from patients attending STD clinics in New Delhi, India were used. The sensitivity, specificity, positive predictive value and negative predictive value of the opa-based PCR were 100%, 97·9%, 89·5% and 100%, respectively. In females, the use of NAATs provided enhanced diagnosis of gonorrhoea.
由于核酸扩增检测 (NAAT) 在低流行地区检测淋病的阳性预测值较差,目前的指南建议使用针对不同基因的聚合酶链反应 (PCR) 作为补充,以确认泌尿生殖道标本中的真正阳性。本研究旨在标准化和评估针对淋病的基于 opa 基因的内部 PCR 检测与针对 porA 假基因和 16S rRNA 基因的检测相比的性能。使用了来自印度新德里 STD 诊所的 400 名患者(300 名宫颈内拭子,100 名尿道拭子)。基于 opa 的 PCR 的敏感性、特异性、阳性预测值和阴性预测值分别为 100%、97.9%、89.5%和 100%。在女性中,NAAT 的使用增强了淋病的诊断。